Your Cart

Notice to IBXO Option Holders

Notice to IBXO Option Holders

The document “Notice to IBXO Option Holders” was lodged with ASX on 14 October, 2021.

Please click to review the full announcement on ASX.

Related Articles

1H2023 Half-Year Results

1H2023 Highlights: Achieved enrolment target for Phase I study of MagSense® HER2 breast cancer detection; imaging results corroborated by independent panel of radiologists Announced plan

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.